Benutzer: Gast  Login
Titel:

Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials.

Dokumenttyp:
Article; Journal Article; Research Support, Non-U.S. Gov't
Autor(en):
Bendor-Samuel, Owen Martyn; Wishlade, Tabitha; Willis, Louise; Aley, Parvinder; Choi, Edward; Craik, Rachel; Mujadidi, Yama; Mounce, Ginny; Roseman, Fenella; De La Horra Gozalo, Arancha; Bland, James; Taj, Nazia; Smith, Ian; Ziegler, Anette-Gabriele; Bonifacio, Ezio; Winkler, Christiane; Haupt, Florian; Todd, John A; Servais, Laurent; Snape, Matthew D; Vatish, Manu
Abstract:
OBJECTIVE: INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral Insulin Trial). METHODS: The majority of participants were recruited by research midwives in antenatal clinics from 18 weeks' gestation. Using the NHS Newborn Bloodspot Screening Programme (NBSP) infrastructure, participants enrolled in INGR1D had an extra sample taken from their day 5 blood...     »
Zeitschriftentitel:
Arch Dis Child
Jahr:
2023
Band / Volume:
108
Heft / Issue:
1
Seitenangaben Beitrag:
26-30
Volltext / DOI:
doi:10.1136/archdischild-2022-324270
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/36171064
Print-ISSN:
0003-9888
TUM Einrichtung:
Klinik und Poliklinik für Kinder- und Jugendmedizin
 BibTeX